Furthermore, the activation of other signalling pathways such as the tumour necrosis factor alpha (TNF-α)/nuclear factor kappa B (NF-kB) pathway enhances melanoma cell growth, and contributes to the failure of chemotherapy treatment including BRAF inhibitors [10]. Here, BRAF is linked to melanoma.